Islet inflammation in type 2 diabetes: from metabolic stress to therapy.

Diabetes care

Volumn 31 Suppl 2, Issue , 2008, Pages

  Donath, Marc Y ^a   Schumann, Desiree M ^a   Faulenbach, Mirjam ^a   Ellingsgaard, Helga ^a   Perren, Aurel ^a   Ehses, Jan A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CYTOKINE; GLUCOSE; INTERLEUKIN 1BETA; LEPTIN;

BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DYSLIPIDEMIA; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS DISEASE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

CYTOKINES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; LEPTIN; OBESITY; PANCREATIC DISEASES;

MLCS; MLOWN;

EID: 41149115561     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-s243     Document Type: Review

References (55)